177 related articles for article (PubMed ID: 31857698)
21.
Tang KL; Tang HY; Du Y; Tian T; Xiong SJ
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31213575
[No Abstract] [Full Text] [Related]
22. DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells.
Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Terada K; Itadani M; Okada N; Hassan NMM; Nagatsuka H; Ikeda T; Nohno T; Fujita S
Oncol Res; 2018 Jan; 26(1):45-58. PubMed ID: 28470144
[TBL] [Abstract][Full Text] [Related]
23. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
[TBL] [Abstract][Full Text] [Related]
24. Functional Transient Receptor Potential Ankyrin 1 and Vanilloid 1 Ion Channels Are Overexpressed in Human Oral Squamous Cell Carcinoma.
Kiss F; Kormos V; Szőke É; Kecskés A; Tóth N; Steib A; Szállási Á; Scheich B; Gaszner B; Kun J; Fülöp G; Pohóczky K; Helyes Z
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163843
[TBL] [Abstract][Full Text] [Related]
25. Integrin-α5 promoted the progression of oral squamous cell carcinoma and modulated PI3K/AKT signaling pathway.
Fan QC; Tian H; Wang Y; Liu XB
Arch Oral Biol; 2019 May; 101():85-91. PubMed ID: 30909080
[TBL] [Abstract][Full Text] [Related]
26. Muc-1 promotes migration and invasion of oral squamous cell carcinoma cells via PI3K-Akt signaling.
Li P; Xiao LY; Tan H
Int J Clin Exp Pathol; 2015; 8(9):10365-74. PubMed ID: 26617744
[TBL] [Abstract][Full Text] [Related]
27. Activation of transient receptor potential vanilloid 4 is involved in pressure overload-induced cardiac hypertrophy.
Zou Y; Zhang M; Wu Q; Zhao N; Chen M; Yang C; Du Y; Han B
Elife; 2022 Jun; 11():. PubMed ID: 35731090
[TBL] [Abstract][Full Text] [Related]
28. TRPV4 disrupts mitochondrial transport and causes axonal degeneration via a CaMKII-dependent elevation of intracellular Ca
Woolums BM; McCray BA; Sung H; Tabuchi M; Sullivan JM; Ruppell KT; Yang Y; Mamah C; Aisenberg WH; Saavedra-Rivera PC; Larin BS; Lau AR; Robinson DN; Xiang Y; Wu MN; Sumner CJ; Lloyd TE
Nat Commun; 2020 May; 11(1):2679. PubMed ID: 32471994
[TBL] [Abstract][Full Text] [Related]
29. Elevated autocrine chemokine ligand 18 expression promotes oral cancer cell growth and invasion via Akt activation.
Jiang X; Wang J; Chen X; Hong Y; Wu T; Chen X; Xia J; Cheng B
Oncotarget; 2016 Mar; 7(13):16262-72. PubMed ID: 26919103
[TBL] [Abstract][Full Text] [Related]
30. Application of a Persistent Heparin Treatment Inhibits the Malignant Potential of Oral Squamous Carcinoma Cells Induced by Tumor Cell-Derived Exosomes.
Sento S; Sasabe E; Yamamoto T
PLoS One; 2016; 11(2):e0148454. PubMed ID: 26849680
[TBL] [Abstract][Full Text] [Related]
31. Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway.
Zhang X; Liu N; Ma D; Liu L; Jiang L; Zhou Y; Zeng X; Li J; Chen Q
Int J Oncol; 2016 Aug; 49(2):539-48. PubMed ID: 27279145
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.
Wang Q; Zhang X; Song X; Zhang L
Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142
[TBL] [Abstract][Full Text] [Related]
33. TRPV4 promotes the migration and invasion of glioma cells via AKT/Rac1 signaling.
Ou-Yang Q; Li B; Xu M; Liang H
Biochem Biophys Res Commun; 2018 Sep; 503(2):876-881. PubMed ID: 29928875
[TBL] [Abstract][Full Text] [Related]
34. TRPV4 regulates matrix stiffness and TGFβ1-induced epithelial-mesenchymal transition.
Sharma S; Goswami R; Zhang DX; Rahaman SO
J Cell Mol Med; 2019 Feb; 23(2):761-774. PubMed ID: 30450767
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological inhibition of TRPV4 channel suppresses malignant biological behavior of hepatocellular carcinoma via modulation of ERK signaling pathway.
Fang Y; Liu G; Xie C; Qian K; Lei X; Liu Q; Liu G; Cao Z; Fu J; Du H; Liu S; Huang S; Hu J; Xu X
Biomed Pharmacother; 2018 May; 101():910-919. PubMed ID: 29635900
[TBL] [Abstract][Full Text] [Related]
36. Activation of PTEN by inhibition of TRPV4 suppresses colon cancer development.
Liu X; Zhang P; Xie C; Sham KWY; Ng SSM; Chen Y; Cheng CHK
Cell Death Dis; 2019 Jun; 10(6):460. PubMed ID: 31189890
[TBL] [Abstract][Full Text] [Related]
37. Novel noncanonical regulation of soluble VEGF/VEGFR2 signaling by mechanosensitive ion channel TRPV4.
Kanugula AK; Adapala RK; Midha P; Cappelli HC; Meszaros JG; Paruchuri S; Chilian WM; Thodeti CK
FASEB J; 2019 Jan; 33(1):195-203. PubMed ID: 29957061
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of PER2 Promotes Tumor Progression by Enhancing Glycolysis via the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Oral Squamous Cell Carcinoma.
Long W; Gong X; Yang Y; Yang K
J Oral Maxillofac Surg; 2020 Oct; 78(10):1780.e1-1780.e14. PubMed ID: 32615095
[TBL] [Abstract][Full Text] [Related]
39. FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway.
Wang X; Chen Q
BMC Oral Health; 2021 Nov; 21(1):598. PubMed ID: 34814915
[TBL] [Abstract][Full Text] [Related]
40. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
Chen M; Zhang J
J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
